These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 2940110)
21. Effect of lacidipine pre-treatment on diabetic neuropathy in rats. Singh J; Aditya S; Lal H; Arora B Arch Physiol Biochem; 2011 Feb; 117(1):12-7. PubMed ID: 21091185 [TBL] [Abstract][Full Text] [Related]
22. Near nerve local insulin prevents conduction slowing in experimental diabetes. Singhal A; Cheng C; Sun H; Zochodne DW Brain Res; 1997 Jul; 763(2):209-14. PubMed ID: 9296561 [TBL] [Abstract][Full Text] [Related]
23. The role of cyclic adenosine 3',5'-monophosphate and polyol metabolism in diabetic neuropathy. Shindo H; Tawata M; Aida K; Onaya T J Clin Endocrinol Metab; 1992 Feb; 74(2):393-8. PubMed ID: 1370506 [TBL] [Abstract][Full Text] [Related]
24. Nerve conduction velocity in experimental diabetes in the rat and rabbit. Thomas PK; Jefferys JG; Sharma AK; Bajada S J Neurol Neurosurg Psychiatry; 1981 Mar; 44(3):233-8. PubMed ID: 7229647 [TBL] [Abstract][Full Text] [Related]
25. Prevention and reversal of defective axonal transport and motor nerve conduction velocity in rats with experimental diabetes by treatment with the aldose reductase inhibitor Sorbinil. Tomlinson DR; Moriarty RJ; Mayer JH Diabetes; 1984 May; 33(5):470-6. PubMed ID: 6202576 [TBL] [Abstract][Full Text] [Related]
26. A quantitative comparison of motor and sensory conduction velocities in short- and long-term streptozotocin- and alloxan-diabetic rats. Moore SA; Peterson RG; Felten DL; O'Connor BL J Neurol Sci; 1980 Oct; 48(1):133-52. PubMed ID: 6448276 [TBL] [Abstract][Full Text] [Related]
27. Nerve conduction changes and fine structural alterations of extra- and intrafusal muscle and nerve fibers in streptozotocin diabetic rats. Weis J; Dimpfel W; Schröder JM Muscle Nerve; 1995 Feb; 18(2):175-84. PubMed ID: 7823975 [TBL] [Abstract][Full Text] [Related]
28. Relative growth and maturation of axon size and myelin thickness in the tibial nerve of the rat. 2. Effect of streptozotocin-induced diabetes. Thomas PK; Fraher JP; O'Leary D; Moran MA; Cole M; King RH Acta Neuropathol; 1990; 79(4):375-86. PubMed ID: 2140232 [TBL] [Abstract][Full Text] [Related]
29. Aminoguanidine--effects on endoneurial vasoactive nitric oxide and on motor nerve conduction velocity in control and streptozotocin-diabetic rats. Dewhurst M; Omawari N; Tomlinson DR Br J Pharmacol; 1997 Feb; 120(4):593-8. PubMed ID: 9051296 [TBL] [Abstract][Full Text] [Related]
30. Effect of aldose reductase inhibition on nerve conduction velocity and resistance to ischemic conduction block in experimental diabetes. Price DE; Airey CM; Alani SM; Wales JK Diabetes; 1988 Jul; 37(7):969-73. PubMed ID: 3133261 [TBL] [Abstract][Full Text] [Related]
31. Effects of adenosine and adenosine A2A receptor agonist on motor nerve conduction velocity and nerve blood flow in experimental diabetic neuropathy. Kumar S; Arun KH; Kaul CL; Sharma SS Neurol Res; 2005 Jan; 27(1):60-6. PubMed ID: 15829161 [TBL] [Abstract][Full Text] [Related]
32. Ganglioside treatment of diabetic rats; effects on nerve adenosine triphosphatase activity and motor nerve conduction velocity. Calcutt NA; Tomlinson DR; Willars GB Life Sci; 1988; 42(16):1515-20. PubMed ID: 2965293 [TBL] [Abstract][Full Text] [Related]
33. Analysis of peripheral nerve function in streptozotocin diabetic rats. Jefferys JG; Brismar T J Neurol Sci; 1980 Dec; 48(3):435-44. PubMed ID: 6255106 [TBL] [Abstract][Full Text] [Related]
34. Rapid reversal of a motor nerve conduction deficit in streptozotocin-diabetic rats by the angiotensin converting enzyme inhibitor lisinopril. Cameron NE; Cotter MA; Robertson S Acta Diabetol; 1993; 30(1):46-8. PubMed ID: 8392403 [TBL] [Abstract][Full Text] [Related]
35. A new prostaglandin E1 analogue (TFC-612) improves the reduction in motor nerve conduction velocity in spontaneously diabetic GK (Goto-Kakizaki) rats. Suzuki K; Saito N; Sakata Y; Toyota T; Goto Y Prostaglandins; 1990 Nov; 40(5):463-71. PubMed ID: 2255766 [TBL] [Abstract][Full Text] [Related]
36. Distal neuropathy in experimental diabetes mellitus. Brown MJ; Sumner AJ; Greene DA; Diamond SM; Asbury AK Ann Neurol; 1980 Aug; 8(2):168-78. PubMed ID: 7425570 [TBL] [Abstract][Full Text] [Related]
37. Effects of chronic treatment with a nitric oxide donor on nerve conduction abnormalities and endoneurial blood flow in streptozotocin-diabetic rats. Cameron NE; Cotter MA Eur J Clin Invest; 1995 Jan; 25(1):19-24. PubMed ID: 7705382 [TBL] [Abstract][Full Text] [Related]
38. Dissociation between biochemical and functional effects of the aldose reductase inhibitor, ponalrestat, on peripheral nerve in diabetic rats. Cameron NE; Cotter MA Br J Pharmacol; 1992 Dec; 107(4):939-44. PubMed ID: 1467842 [TBL] [Abstract][Full Text] [Related]
39. Amelioration of nerve Na(+)-K(+)-ATPase activity independently of myo-inositol level by PGE1 analogue OP-1206.alpha-CD in streptozocin-induced diabetic rats. Sonobe M; Yasuda H; Hisanaga T; Maeda K; Yamashita M; Kawabata T; Kikkawa R; Taniguchi Y; Shigeta Y Diabetes; 1991 Jun; 40(6):726-30. PubMed ID: 1645681 [TBL] [Abstract][Full Text] [Related]
40. Nerve conduction velocity, laser Doppler flow, and axonal caliber in galactose and streptozotocin diabetes. Kalichman MW; Dines KC; Bobik M; Mizisin AP Brain Res; 1998 Nov; 810(1-2):130-7. PubMed ID: 9813281 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]